The
interaction of cobalt phthalocyanine disodium disulfonate (CoPc)
with calf thymus DNA in solutions was investigated by UV/vis spectrophotometry,
circular dichroism (CD), and hydrodynamic methods (viscosity and flow
birefringence). Two types of CoPc binding to DNA were observed. Fast
CoPc interactions with DNA via external binding to phosphates were
accompanied by the formation of stack-type phthalocyanine structures
on the periphery of the DNA helix. The optical absorption spectra
of such CoPc complexes with DNA were analyzed in order to obtain a
binding constant K = (4.8 ± 0.4) × 104 M–1. CD spectra show the increasing optical
activity of phthalocyanines bonded to DNA. DNA plays the role of a
matrix, contributing to an increase in their stacking interactions.
The CD spectrum of DNA varies slightly. The second type of cobalt-to-DNA
binding manifests itself over a certain time. It can be associated
with the reorganization of ligands in the cobalt coordination sphere
by introducing DNA atoms. In our experiments, such binding was observed
after storage of solutions for approximately 20 h at a temperature
of 4 °C. It was shown that the minor groove of DNA remains free
in CoPc–DNA complexes. CoPc does not bind with the most important
group for metal coordinating to DNA in the major groove (N7 guanine).
We completely excluded the intercalation binding model. The planes
of phthalocyanines in CoPc–DNA complexes are oriented predominantly
normal to the axis of the DNA helix. DNA rigidity (persistent length)
does not change. This follows from the data on the measurement of
the optical anisotropy and intrinsic viscosity of DNA in complexes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.